Advisory Research’s Mesoblast MESO Stock Holding History

Advisory Research’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-22,758	Closed	-$846K	–	330
2020 Q3	$846K	Buy	+22,758	New	+$713K	0.08%	191

Other funds holding MESO

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PCM

Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Advisory Research's MESO Position: Q4 2020 in Review

Advisory Research sold out of Mesoblast (MESO) in Q4 2020, closing a stake of 22,758 shares — an estimated $846K sold.

Advisory Research first reported a position in MESO in Q3 2020 and held it in 1 quarter. The position peaked at $846K in Q3 2020. 53 funds tracked by Wall St. Rank hold MESO as of Q4 2020.

Advisory Research reported no remaining Mesoblast position as of Q4 2020 after selling out during the quarter.
Advisory Research sold 22,758 Mesoblast shares in Q4 2020, an estimated $846K.
Advisory Research first reported a position in Mesoblast in Q3 2020 and held it in 1 quarter.
Advisory Research's Mesoblast position peaked at $846K in Q3 2020.
53 funds tracked by Wall St. Rank held Mesoblast as of Q4 2020.

Based on Advisory Research's 13F filing for Q4 2020, filed 12 Feb 2021.